• About Cervical Check

  • How does CervicalCheck operate?

    CervicalCheck is an organised, population-based, quality assured cervical screening programme. CervicalCheck has developed and maintains the secure Cervical Screening Register with the details of eligible woman aged 25 to 60 nationwide. The details of eligible women are sourced from the Department of Social Protection and from women through registration and attendance for cervical screening in practice.

    Letters of invitation are issued to unscreened women.

    CervicalCheck sends an invitation letter by post to every eligible woman on the Cervical Screening Register who has never had a CervicalCheck screening test. The letter invites her to make an appointment with a registered doctor or nurse for her first free test. If the woman does not attend for a screening test, she is sent up to two reminder letters.

    If an eligible woman has not yet had a CervicalCheck test or has not received a letter from CervicalCheck, she can just go to a CervicalCheck registered doctor or nurse for her first screening. CervicalCheck may not have the details of the woman but having a test and sending a completed cervical screening form ensures she is part of the programme.

    Eligible women must be normally resident and have a postal address in the Republic of Ireland.

    Letters of re-call are issued to previously screened women after the appropriate interval.

    Routine screening intervals are every three years for women aged 25 to 44 and every five years for women aged 45 to 60, in line with best international practice.

    Letters to advise women when the result of their screening test is available and to recommend their next step within the screening programme are issued within four weeks of having their test taken.

    Quality assured colposcopy services located in 15 hospitals are available for women who require follow-up investigation and treatment if necessary.

  • What is cervical screening?

    In accordance with Wilson and Jungner’s principles of screening, cervical cancer is an important health problem. It has an acceptable screening test, a natural history that allow for early detection and a curative treatment for cervical abnormalities identified. There are several points to understand relating to cervical screening.

    Cervical screening is not a test for cancer.

    It looks for cell changes in the cervix Abnormal changes in the cells of the cervix if left untreated could become cancerous.

    Currently the test involves cytology where cells are harvested from the neck of the womb and may involve H-P-V testing. In May 2017, the Health Information and Quality Authority advised that CervicalCheck change its primary screening method to H-P-V testing. Plans to implement the change are underway at time of writing.

    There are 2 types of epithelium in the cervix, these are Squamous epithelium which has a protective role similar to skin, and Columnar (glandular) epithelium which produces mucous. Pre invasive and invasive cervical cancer can arise in either of these cell types. Pre invasive and invasive cervical cancer can arise in either of these cell types.

    The cervical cytology screening test is a sensitive test for detection of squamous cell changes in the cervix, but it is less sensitive for the detection of glandular cell changes. This is because the area of the cervix with glandular epithelium is more difficult to sample and also because the cell changes in glandular cells are much more difficult to identify under the microscope compared to cell changes in squamous cells. Despite this many glandular lesions are detected by the cervical screening test and similar to squamous cell changes the earlier these changes are found the easier they are to treat.The statistics suggest that one in five cancers of the cervix are adeno carcinomas which originate in the columnar (glandular) epithelium.

  • Organised versus opportunistic screening?

    A cervical screening test is not a diagnostic test. Opportunistic screening is not effective and does not impact on levels of detection of cervical cancer. Consistent with best international practice, opportunistic screening outside programme screening intervals (e.g. routine screening of pregnant or post-natal women, routine screening of women using contraception, HRT or routine screening of women undergoing investigation for genital infection or for those previously used to excessively frequent screening) is considered inappropriate. Consistent with international best practice, opportunistic screening is discouraged. If a woman presents to a doctor or nurse with symptoms suggestive of gynaecological cancer the woman should be referred directly for urgent gynaecological review. Opportunistic screening is prevalent in post natal follow-up care. This is not the ideal time for effective test taking and should be discouraged to correct the inappropriate link between pregnancy and screening tests.

  • What are the benefits and limitation of screening?

    Cervical screening benefits: Cervical screening can reduce the number of cases of cervical cancer over time. A cervical screening test can detect early changes in the cells of the cervix, before symptoms appear. Identifying these early cell changes helps to prevent the development of cervical

    Cervical screening limitations: The screening process is not without risk or harm to the person, either physical or psychological. Cervical screening will not prevent all cases of cervical cancer. Cervical screening tests, like other screening tests, are not 100% accurate. Even with best practice both squamous cell carcinoma and adeno carcinoma of the cervix can go undetected. A result may be deemed negative even though there are changes to the cells of the cervix (this is called a false negative). This is why it is important to have regular tests and to advise women to consult their doctor if they experience any symptoms such as abnormal vaginal bleeding or unusual discharge. A result may be positive even though there are no changes in the cells of the cervix (this is called a false positive). Some women may be treated for abnormalities that may have cleared up on their own.

  • What is the screening range for women in CervicalCheck?

    International best practice recommends that a population based cervical screening programme should target women aged from 25 or 30 years to 60 or 65 years.

    Based on evidence to date, there is no additional public health benefit in starting screening below the age of 25. In women under the age of 25, minor changes in the cells of the cervix are common but invasive cancer is extremely rare. Population based screening in women under the age of 25 may lead to many women receiving unnecessary treatment for lesions that would never have developed into invasive cancer. Once screening begins at the age of 25, lesions that are likely to progress will be screen-detectable. Lesions that regress will no longer be a source of concern. Any woman under the age of 25 who is concerned about her risk of developing cervical cancer or her sexual health should contact her doctor or Genito-Urinary Medicine (GUM) clinic.

    There is no firm evidence that indicates the optimal age to cease screening but in most international programmes it is 60 or 65. Women aged 60 and over who have never had a screening test are entitled to have a CervicalCheck test.

    Effectiveness of cervical screening with age: population based case- control study of prospectively recorded dataArticle from the Brittish Medical Journal first published in August 2009

  • How often are women screened?

    CervicalCheck operates two routine screening intervals for women with normal screening test results.

    Women aged 25 to 44 will be invited routinely for a free screening test every three years and following two consecutive normal test results women aged 45 to 60 will be invited routinely every five years.

    Women who join the programme when aged 45 or over will need to have two normal test results three years apart before they move onto a five yearly re-call.

    Womenwho are recommended for increased surveillance are re-called after one year following a normal test result.

    Women who receive unsatisfactory results will be recommended for a repeat test after 3 months. The test should not be repeated before 3 months. This is the minimum repeat interval, to allow time for the cells of the cervix to grow back after a screening test.

    Following a screening test, CervicalCheck sends a letter to the woman advising her of her recommended next step in the screening programme. The recommended next step may be: routine screening, annual screening, early repeat (in 3 or 6 months), or to contact her the doctor or nurse who took the test to discuss her result and recommendation.

  • How do I check if a woman is eligible for screening?

    CervicalCheck has developed a reference framework for Health Professionals which provides guidance on the eligibility criteria for women with respect to age, screening intervals, management recommendations and special circumstances.

    CervicalCheck eligibility framework

    A woman's eligibility for a CervicalCheck screening test may be checked on the website using the Check Woman's Eligibility facility.

  • What does informed consent mean?

    Each woman must provide her informed consent in order to participate. Evidence of consent indicates:

    1. That they have been informed about and have understood cervical screening and its benefits and limitations.

    2. That they allow CervicalCheck to receive, store and share their personal details and screening history with those engaged to deliver and support the CervicalCheck programme

    A woman's consent, by signature or by witnessed mark, is required to participate in CervicalCheck. Only the woman herself may provide consent. Consent to participate can never be given by a third party.

    Before signing the Cervical Cytology Form, a woman has the right to certain information to allow her to make an informed choice and to give informed consent. This includes an explanation of:

    1. The screening tests including the possibility that the sample may also be tested for certain types of HPV

    2. The likelihood and meaning of a normal result.

    3. What it means if recalled for further tests

    4. When and how the result will be provided

    5. The importance of having regular screening tests

    6. The accuracy and limitations of screening tests, and

    7. If the results are abnormal, the options available, including an assessment of the risks, limitations, side effects and benefits of each option.

    A woman must sign the Cervical Cytology Form to take part in the programme and avail of a free CervicalCheck test. The Information Sheet for Women (cover sheet of the Cervical Cytology form) must be provided to every woman who attends for a test. It explains to a woman how her consent is required to allow her personal details to be shared within the cervical screening programme.

    The Information Sheet for Women (cover sheet of the Cervical Cytology form) is available in a number of language translation to faciliate women providing informed consent in advance of a screening test. In addition to English and Irish, translations are available in Arabic, Chinese (Mandarin), French, German, Latvian, Lithuanian, Polish, Romanian, Russian and Spanish.

    All information sheets are available to view and download in the Essential documents section

  • Programme reports and related publications
  • Registration of doctors, nurses, GP practices, clinics

  • Engaging in a contract with CervicalCheck?

    In order to provide cervical screening within the CervicalCheck programme, at least one doctor within a GP practice or clinic must engage in a contract with the HSE National Screening Service (NSS) for the provision of cervical screening services.

    A GP, medical practitioner or medical director of a clinic operating in a primary care setting may seek to engage in a contract for the provision of cervical screening services. The enquiry to engage in a contract for cervical screening should be directed to the CervicalCheck programme office, indicating whether the enquiry applies to a GP practice or to a clinic.

    Programme office: tel: 061 406500 or email: admin@cervicalcheck.ie

    The programme office will issue a contract registration pack.

    When the completed contract and registration documentation is received and processed, the programme office will acknowledge receipt of documentation and notify the commencement date of the contract.

    A doctor should complete the online CervicalCheck in Practice module before commencing cervical screening within CervicalCheck. The short module provides instructions and best practice in cervical screening, in accordance with the Guidelines for Quality Assurance in Cervical Screening.

  • Registering to take screening tests for CervicalCheck?

    A contracted GP or a clinical director in a contracted clinic may register one or more additional doctors and nurses (qualified persons) who may provide programme screening tests to eligible women.

    Qualified persons include GPs, doctors, assistant GPs, nurses and trainee GPs. All qualified persons (doctors and nurses) must be registered with the Medical Council or the Nursing and Midwifery Board of Ireland as appropriate.

    The contracted GP or the clinical director of a contracted clinic is required to assume clinical responsibility for all cervical screening tests carried out by a qualified person registered by them.

    Payments are made to the contracted GP or clinic for tests for eligible women taken by the qualified persons registered by them.

    A separate qualified persons registration form is required for each qualified person, which must be signed by the clinically responsible doctor (the contracted GP or clinical director). Where a qualified person (doctor or nurse) is employed by more than one contracted doctor, a separate qualified persons form must be signed by each contracted doctor.

    A doctor or nurse should complete the online CervicalCheck in Practice module before commencing cervical screening within CervicalCheck. The short module provides instructions and best practice in cervical screening, in accordance with the Guidelines for Quality Assurance in Cervical Screening.

    The QP registration form is available to download by clicking on the appropriate link below.

    Qualified Person Registration Form - GP Practice

    Qualified Person Registration Form - Clinic

  • Change in registration details?

    All relevant changes of details of either a doctor or nurse or of the GP practice or clinic where they work should be notified as soon as possible to the CervicalCheck programme office. This ensure that information displayed on the CervicalCheck website is accurate.

    Changes related to a doctor or nurse that should be notified include:

    • a contracted doctor leaving the practice or clinic

    • a registered doctor or nurse leaving the practice or clinic

    • a change of status of a doctor e.g. from trainee GP to assistant GP.

    Changes related to a GP practice or clinic that should be notified include:

    • a change of address

    • a change of telephone number

    • a change in the facilities e.g. the addition of wheelchair access

    • a change in email or website addresses.

    CervicalCheck may be notified using the Change of Details Form or by email to admin@cervicalcheck.ie.

  • Ending a contract?

    Where a contracted doctor or clinic no longer wishes to retain a contract, formal written notice must be provided to the NSS. This requirement is included in the contract. Queries should be directed at

    Programme office: tel: 061 406500 or
    email: admin@cervicalcheck.ie

  • Website listing of registered doctors and nurses

    The contact details of all contracted GPs and clinics are made available on the CervicalCheck website. This assists women who are seeking to participate in CervicalCheck. GPs and clinics may also have registered doctors and nurses listed on the website. See Where can I have a test? to view the listing.

  • Key identifiers on the Cervical Screening Form

  • Why is the Personal Public Service Number (PPS No.) requested on the form?

    The Personal Public Service Number (PPS No.) is a unique identifier for each person. Its use by CervicalCheck is to ensure that a screening test result is matched with the right woman on the Cervical Screening Register. In turn, this ensures that CervicalCheck will issue a letter to the right woman advising her of her next step in the screening programme.

    In addition, the Primary Care Reimbursement Scheme (PCRS) requires a woman’s PPS No. for payment processing and reimbursement. If a woman does not have a PPS No. she can still participate in CervicalCheck.

  • What is the CSP ID and does it need to be recorded on the form?

    The CSP ID is a unique identifier assigned to each woman on the Cervical Screening Register.

    The CSP ID is included on all correspondence issued from the programme in relation to a woman. The Woman’s Eligibility Check facility on this website will also provide a woman’s CSP ID if the details entered are correct.

    The CSP ID will only be present on a cytology result to a doctor if the number is recorded on the Cervical Cytology Form at the time of taking the test.

    It is not mandatory to record the CSP ID on the Cervical Cytology Form but where it is available it should be provided. As a unique identifier, it helps to ensure that a screening event is matched to the right woman’s record.

  • HPV Testing

  • How is HPV testing used in CervicalCheck
    HPV triage - reflex HPV testing

    Women who attend for cervical screening will have their samples also tested for HPV if cytology detects low grade abnormalities (ASCUS or LSIL). The HPV test helps to determine the recommen dation to be assigned with the result by the laboratory. This recommendation will be for routine screening if HPV is not detected, and will be refer to colposcopy if HPV is detected.

    Women who are referred to colposcopy with low grade cytology and HPV deteced will have a colposcopy and/or a biopsy. If there is no CIN present, these women will be discharged for a screening test in 3 years (regardless of age). If there is CIN present, these women will be managed in colposcopy until they can be discharged.

    If a woman is on a post LLETZ follow up regime and has a HPV Reflex test, she will be re-called in three years (routine re-call) because the result of the reflex HPV test supersedes any original discharge management from colposcopy

    HPV testing within colposcopy services

    Women are offered combined smear and HPV tests in programme colposcopy clinics. The combined smear and HPV tests are used for women post treatment, and for women with persistent low grade cytological abnormalities but who do not require treatment.

    For women who are post treatment, HPV testing is designed to improve the early detection of women who may require repeat treatment. In addition, HPV testing informs the risk assessment of women prior to discharge, and can lead to discharge recommendations of routine screening (rather than annual surveillance screening) for increased numbers of women.

  • Why is HPV testing done following colposcopy treatment?

    HPV testing is designed to improve the early detection of women who may require repeat treatment and to avoid increased testing for women at low risk of recurrence. The traditional follow up of treated women involved annual cytology screening for 10 years before they return to routine screening. The introduction of HPV testing will allow many women to avoid annual tests.

  • Can a HPV test be ordered in Primary Care through CervicalCheck?

    No, it is not possible to order a HPV test in primary care through CervicalCheck at this time. HPV testing is only being provided as a reflex test when low grade cytological abnormalities are found in a screening smear test sample. Separately, HPV testing is used in CervicalCheck colposcopy settings.

  • Where can I learn more about HPV and HPV testing?

    Evidence based papers and further reading:

    Castellsagué X. (2008) Natural history and epidemiology of HPV infection and cervical cancer. Gynecol Oncol. 2008 Sep;110(3 Suppl 2): Unit of Infections and Cancer, Institut Català d'Oncologia, IDIBELL, CIBER-ESP. S4-7xcastellsague@iconcologia.net

    Cuschieri KS, Cubie HA. (2005) The role of human papillomavirus testing in cervical screening. J Clin Virol. 2005 Mar;32 Suppl 1:S34-42.

    Jones J, Saleem A, Rai N, Shylasree TS, Ashman S, Gregory K, Powell N, Tristram A, Fiander A, Hibbitts S. (2011) Human Papillomavirus genotype testing combined with cytology as a 'test of cure' post treatment: the importance of a persistent viral infection. J Clin Virol. 2011 Oct;52(2):88-92. Epub 2011 Aug 9.

    Matsumoto K, Oki A, Furuta R, Maeda H, Yasugi T, Takatsuka N, Hirai Y, Mitsuhashi A, Fujii T, Iwasaka T,et al. (2010) Tobacco smoking and regression of low-grade cervical abnormalities. Cancer Sci 2010;101:2065–2073.

    MCCaffrey K, Waller J, Nazroo J, Wardle J, (2006). Social and Psychological impact of HPV testing in Cervical Screening: A qualitative study. Sex transm infect 2006; 82(2): 169-74.

    McIntyre-Seltman, K., Castle, P., Guido, R., Schiffman, M., Wheeler, C. (2005): Smoking is a Risk Factor for Cervical Intraepithelial Neoplasia Grade 3 among Oncogenic Human Papillomavirus DNA–Positive Women with Equivocal or Mildly Abnormal Cytology. Cancer Epidemiology Biomarkers & Prevention Vol. 14, 1165-1170.

    Mesher D, Szarewski A, Cadman L, Cubie H, Kitchener H, Luesley D, Menon U, Hulman G, Desai M, Ho L, Terry G, Williams A, Sasieni P, Cuzick J. (2010): Long-term follow-up of cervical disease in women screened by cytology and HPV testing: results from the HART study. Br J Cancer. 2010 Apr 27;102(9):1405-10. Epub 2010 Mar 30.

  • Referral to Colposcopy

  • Where are the CervicalCheck Colposcopy clinics located?

    CervicalCheck has established a network of quality assured colposcopy clinics for women requiring further investigation following a screening test. A woman can be referred to one of 15 colposcopy clinics located nationwide.

    A small minority (two to five per cent) of all women screened will require further investigation or treatment at a colposcopy service.

    CervicalCheck-generated referrals for colposcopy should be sent to one of the 15 programme colposcopy services.

    CervicalCheck colposcopy clinics

    The locations of the colposcopy services are shown on the map.

    Click on the name of a colposcopy service below to obtain its address and contact details.




    Adelaide & Meath and National Children's Hospital (AMNCH)

    Contact Details:

    Tallaght, Dublin 24
    Tel: 01 4144752 01 4143351 01 4143109 01 4143983
    Fax: 01 4144725

    Key Staff

    Lead Clinician:

    Dr Cliona Murphy

    Nurse Colposcopist:

    Mary Martin, Sinead Cleary

    Colposcopy Nurse Specialist:

    Amy Loughlin

    Trainee Nurse Colposcopist:

    Claire Fry

    Colposcopy Nurse:

    Michelle Griffin
    Mary McNamara
    Patrice Tierney

    Colposcopy Administration:

    Róisín Hogan, Office Manager
    Jacinta Purcell, Administration
    Catherine Purcell, Administration
    Anne Murray, Administration

    Hospital Website:





    St Finbarr's Hospital

    Contact Details:

    Douglas Road, Cork
    Tel: 021 4966555/ 021 4923300

    Fax: 021 4923301

    Key Staff

    Lead Clinician:

    Dr Matt Hewitt

    Colposcopy Nurse Specialist:

    Dara Philpott, Alysia Dooling, Mary O'Regan and Christina Murphy

    Colposcopy Administration:

    Carmel Cummins

    Hospital Website:





    Coombe Women & Infant's University Hospital

    Contact Details:

    Dolphins Barn, Dublin 8

    Tel: 01 4085768/01 4085220/ 01 4085471/01 4085510/01 4085759
    Fax: 01 4085727

    Key Staff:

    Olivia McCarthy, Clinical Nurse Manager 2

    Lead Clinician:

    Dr Tom D'Arcy

    Nurse Colposcopist:

    Aoife Kelly

    Trainee Nurse Colposcopists:

    Yvonne McCudden, Feba Paul

    Colposcopy Administration:

    Bernie Cummins, Office Manager
    Joan McNeaney, Administration
    Helen Conlon, Administration
    Frances Cunningham, Administration

    Hospital Website:





    Louth County Hospital

    Contact Details:

    North East Regional Colposcopy Unit, Louth Hospital, Dundalk, Co Louth
    Tel: 042 9364222
    Fax: 042 9389850

    Key Staff

    Lead Clinician:

    Dr Rosemary Harkin

    Nurse Colposcopists:

    Karen Clinton, Marina O'Reilly

    Colposcopy Administration:

    Donna Roe, Jennifer Rogers, Olivia Walsh




    University College Hospital Galway

    Contact Details:

    Newcastle Road, Galway
    Tel: 091 544536/091 542831/ 091 544530/ 091 524222
    Fax: 091 514021

    Key Staff:

    Maura Molloy, Advanced Midwife Practitioner

    Lead Clinician:

    Dr Michael O'Leary

    Nurse Colposcopist:

    Pat Rogers, Rachel Comer

    Colposcopy Administration:

    Caitriona O'Toole




    Kerry General Hospital

    Contact Details:

    Tralee, Co Kerry
    Tel: 066 7184000/ 066 7184189
    Fax: 066 7103108
    Email: susan.foley2@hse.ie

    Key Staff

    Lead Clinician:

    Dr Noirin Russell

    Nurse Colposcopist:

    Colposcopy Nurse Specialist:

    Susan Foley, Maureen Hayes-Considine

    Colposcopy Administration:

    Ann Lucitt




    Letterkenny General Hospital

    Contact Details:

    Letterkenny, Co Donegal
    Tel: 074 9104497 Extension: 4624/2905/2906
    Fax: 074 9104689

    Key Staff

    Lead Clinician:

    Dr. Eddie Aboud

    Nurse Colposcopist:

    Regina McCabe, Patricia Hirrell

    Colposcopy Nurse Specialist:

    Colposcopy Administration:

    Tina Kelly, Linda Shiels




    Mid West Regional Maternity Hospital

    Contact Details:

    Ennis Road, Limerick
    Tel: 061 483110 / 483111 / 483173

    Fax: 061 483112

    Key Staff

    Lead Clinician:

    Dr Kevin Hickey

    Nurse Colposcopist:

    Sheila O'Donnell

    Colposcopy Nurse/Midwives

    Lena Carroll

    Colposcopy Administration:

    Ann Cotter, Mairead DeSuin, Marguerite Jones




    Mayo General Hospital

    Contact Details:

    Castlebar, Co. Mayo
    Tel: 094 9042631
    Fax: 094 9042683
    Email: ann.lavelle@hse.ie

    Key Staff:

    Dr Maebh Ní Bhuinneain, Consultant Colposcopist

    Lead Clinician:

    Dr Ulrich Bartels

    Nurse Colposcopist:

    Dr Meabh Ni Bhuinneain

    Colposcopy Nurse Specialist:

    Ita Lynskey

    Colposcopy Administration:

    Ann Lavelle, Siobhan Gallagher




    National Maternity Hospital

    Contact Details:

    Holles Street, Dublin 2
    Tel: 01 6373100/ 01 6373454/ 01 6373484
    Fax: 01 6373191
    Email: colposcopy@nmh.ie

    Key Staff

    Lead Clinician:

    Dr Grainne Flannelly

    Colposcopy Nurse Specialist:

    Jennifer Fitzgerald

    Colposcopy Administration:

    Geraldine Kennedy

    Hospital Website:





    Rotunda Hospital

    Contact Details:

    Parnell St, Dublin 1

    Main Hospital switchboard: 01 8171700
    Colposcopy Unit - for appointments: 01 8176841
    Colposcopy Nurse Specialists - for information on colposcopy and treatments:
    01 8176844 / 01 8176874 / 01 8172518

    Fax: 01 8171733
    Email: colptl@rotunda.ie

    Key Staff

    Lead Clinician:

    Dr Paul Byrne

    Key Staff:

    Ms Selena Igoe - Colposcopy Nurse Coordinator

    Colposcopy Administration:

    Ms Susan Daly

    Colposcopy Nurse Specialists:

    Ms Carol O'Rourke, Ms Rose Thorne, Ms Jennifer O'Neill, Ms Virginie Bolger






    Sligo Regional Hospital

    Contact Details:


    Main Hospital switchboard: 071 9171111

    Colposcopy Unit - for appointments: 071 91736818
    Colposcopy Nurse Specialists - for information on colposcopy and treatments:
    071 9174708 / 071 9136870

    Fax: 071 9174709
    Email: sinead.griffin@hse.ie

    Key Staff

    Lead Clinician:

    Dr Vimla Sharma

    Nurse Colposcopist:

    Sinéad Griffin

    Colposcopy Nurse Specialist:

    Jennifer Curley

    Colposcopy Administration:

    Patricia Murphy and Sharon Finnegan




    South Tipperary General Hospital

    Contact Details:

    St. Joseph’s Hospital, Clonmel, Co. Tipperary
    Tel: 052 6177983

    Fax: 052 6177011

    Key Staff

    Lead Clinician:

    Dr Vijayashrae Hiremath

    Colposcopy Nurse Specialist:

    Mary O’Hanlon

    Colposcopy Administration:

    Jenny Kennedy




    Waterford Regional Hospital

    Contact Details:

    Dunmore Road, Waterford
    Tel: 051 842067 / 051 842160 / 051 848000

    Fax: 051 848800

    Key Staff

    Lead Clinician:

    Dr John Stratton

    Nurse Colposcopist:

    Brigita Moore, Anastasia McGuigan

    Colposcopy Administration:

    Nance O’Meara




    Wexford General Hospital

    Contact Details:

    Newtown Road, Wexford
    Tel: 053 9142233 /053 9153250/ 053 91 53024

    Fax: 053 9153078

    Email: AnneR.Redmond@hse.ie

    Key Staff

    Lead Clinician:

    Dr Francois Gardeil

    Nurse Colposcopist:

    Anne Roche Redmond

    Colposcopy Nurse Specialist:

    Joanne Watchorn, Sheila McCabe

    Colposcopy Administration:

    Maria Lacey

  • CervicalCheck has recommended a specific colposcopy service: can this be changed?

    When a screening test result for a woman carries a recommendation of refer to colposcopy, doctors are advised by letter of a recommended colposcopy service for the referral. The recommendation is based upon the proximity of the practice to a colposcopy service where a woman will receive an early appointment.

    If a woman or a doctor wishes to change the colposcopy service, the doctor can use the ‘amend colposcopy referral’ facility in the left-hand panel. The programme will be automatically notified of the change.

    Further information:

  • What is required when referring a woman to colposcopy?

    When referring a woman to colposcopy, the doctor should:

    • Discuss the requirement for referral with the woman

    • Decide the colposcopy service for the referral

    • Use a Colposcopy referral form

    • Document clinical findings

    • For a referral following an abnormal cytology result, include the cytology report with the referral.

  • Failsafe requests

  • What is a failsafe request?

    A failsafe request is a written request sent by CervicalCheck to the doctor with clinical responsibility for a woman’s last screening test if the woman does not attend for:

    • a recommended early repeat test (following an inadequate or abnormal result)

    • a recommended colposcopy referral

    • a recommended post colposcopy follow up test.

    A letter is also sent to the woman reminding her of the recommended action. The failsafe process operated by CervicalCheck is designed to ensure that all abnormal results are appropriately followed up.

    Failsafe requests are sent 2 months after the due date for the woman’s recommended screening event – repeat screening test or appointment in a colposcopy service.

    The doctor’s response to the failsafe request is used to appropriately update the woman's record on the Cervical Screening Register, in order to facilitate her appropriate cervical screening management.

    Doctors who receive an Abnormal Follow up form for a woman from the programme may provide the response to CervicalCheck online using the ‘Respond to failsafe request’ facility. This avoids paper forms and postage.

    Further information:

  • How does a doctor respond online to a failsafe request?

    Use the ‘Respond to failsafe request’ facility. The doctor’s ID and the woman’s Cervical Screening Programme (CSP) ID are included on the Abnormal Follow up form sent to the doctor. These details are required to access the response facility.

    The requested information can be quickly entered and then submitted, and an acknowledgment of the response can be printed for a doctor’s records.

    Further information:

  • Why is a second failsafe request for the same woman received by the doctor?

    In order to follow up a woman’s recommended screening events, CervicalCheck will issue a second failsafe request to the doctor and a letter to the woman two months after the first request if the recommended screening test or appointment at colposcopy has still not occurred and no response was received to the first request.

    It may happen that a response is sent by the doctor close to two months after the first request, but has not been processed before the second request issues.

    Doctors are advised that the online Respond to failsafe request is the easiest and quickest means to respond to a failsafe request.

    Further information:

Last modified: Friday, 13 April 2018, 2:20 PM